top of page
  • Writer's pictureWilliam Werkmeister

Prevetric's Platform Aimed at Disrupting Digital Standard of Care for Monitoring Hypertension

Traditional methods for measuring hypertension are both highly inaccurate and concerningly outdated. The arbitrary approach of trial-and-error results in increased risk of complications from diabetes, strokes, atrial fibrillation, congestive heart failure, chronic kidney disease, and a range of other potential co-morbidities. Despite living in a world of technological, genetic, and medical innovation, controllable medical conditions are continuing to take the lives of millions.

Preventric, a Birmingham based digital health company, is providing solutions which are focused on the world's most significant vascular health disorders - including hypertension, cardiovascular disease, cognitive health, and renal disease, which will have a broad impact on the US healthcare system. Through its wearable BPro® technology, Preventric seeks to accelerate precision medicine to reduce vascular disease progression worldwide with its advanced blood pressure data. The Company expects to disrupt the century-old paradigm of one-time, office measurement and transform the process for diagnosing vascular related disorders. Prevetric says its Vascular Health Intelligence® platform will become the “Digital Standard of Care” for managing hypertension and related vascular diseases.

BPro® is an elegant, cuffless, wrist-wearable device that provides revolutionary 24-hour hemodynamic insights. With 21 clinical trials on over 20,000 patients, 70 peer-reviewed papers, eight U.S. Patents, FDA clearance, and permanent reimbursement codes Preventric believes its BPro® technology will change the future of hypertension diagnosis and management. BPro® is able to measure central blood pressure and arterial waveforms with 99.17% accuracy of an arterial line. The BPro® implementation model is similar to that of existing Holter Monitors, making the integration of BPro® into practices more seamless. The Company says that all current competitors utilize uncomfortable cuff-based blood-pressure devices.

Preventric says their Vascular Health Intelligence® platform enables precision information, which drives life-changing care, and results in better outcomes with lower healthcare expenses. With over 100 million Americans suffering from hypertension, Preventric is confident in the a unique opportunity to change the lives of millions of Americans and also create a digital health ecosystem with multiple facets for revenue.

The Preventric team recently partnered with Syneos, to commercialize the BPro® device in physician offices across America. Preventric is also an innovator in the American Heart Association Center for Health Technology & Innovation and a member of the JP Morgan Life Science Accelerator program.

1 view0 comments


bottom of page